ESMO 2023 Highlights: Developments in Melanoma
Join Marco Donia as he discusses the intriguing results on melanoma, presented at ESMO 2023. While no groundbreaking shifts occurred, some of the notable findings include promising responses in rare melanoma subtypes, novel combinations for uveal melanoma, and potentially life-changing treatments for brain metastasis patients, on which he elaborates in this MEDtalk.
Få tilgang
Hvis du er lege, sykepleier eller annen helsepersonell, kan du få tilgang til hele artikkelen ved å opprette en profil på BestPractice Nordic.
- Få tilgang
- Hvis du allerede har en profil: Logg in